VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
DLB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
DLBDolby Laboratories, Inc.
$50.04$4.8B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. DLB
  4. Financial Ratios

Dolby Laboratories, Inc. (DLB) Financial Ratios

Latest Ratios: P/E Ratio 19.1x · EV/EBITDA 11.3x · ROE 10.0%. (2003–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

DLB Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$4.8B$7.1B$7.4B$7.7B$6.6B$9.7B$6.7B$6.7B$7.5B$5.9B$5.6B
Enterprise Value$4.1B$6.4B$6.8B$7.0B$6.1B$8.5B$5.7B$5.9B$6.6B$5.3B$5.0B
P/E Ratio →19.1027.6328.1140.4435.9931.1328.8826.1461.3829.5029.99
P/S Ratio3.545.235.785.955.307.555.765.377.105.495.42
P/B Ratio1.852.682.963.262.953.712.742.883.412.772.81
P/FCF11.1116.4024.7622.9725.6424.6024.3431.1528.0521.7740.21
P/OCF10.1314.9422.4921.0720.8621.6119.4620.3621.2515.7315.44

P/E links to full P/E history page with 30-year chart

DLB EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—4.745.365.364.846.644.904.726.224.914.91
EV / EBITDA11.3317.5919.4019.4418.9119.5018.2715.4824.8215.3515.84
EV / EBIT15.5422.8421.8527.8628.1824.0123.7420.7833.4120.6821.37
EV / FCF—14.8622.9720.6923.4121.6520.7127.3924.5819.4436.45

DLB Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin88.1%88.1%89.0%88.3%88.7%89.9%87.4%87.0%87.9%89.1%89.4%
Operating Margin19.6%19.6%20.8%20.2%17.3%26.6%19.0%23.6%17.4%24.2%22.7%
Net Profit Margin18.9%18.9%20.6%15.4%14.7%24.2%19.9%20.5%4.0%18.7%18.1%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE10.0%10.0%10.8%8.7%7.6%12.3%9.7%11.3%1.9%9.8%9.8%
ROA8.0%8.0%8.5%7.0%6.3%10.2%8.0%9.0%1.5%8.3%8.4%
ROIC10.1%10.1%11.2%12.0%10.5%17.7%11.2%15.9%9.9%13.2%12.8%
ROCE9.6%9.6%10.0%10.5%8.3%12.4%8.5%11.5%7.5%11.9%11.6%

DLB Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity0.010.010.020.020.020.030.03————
Debt / EBITDA0.110.110.130.140.160.170.26————
Net Debt / Equity—-0.25-0.21-0.32-0.26-0.45-0.41-0.35-0.42-0.30-0.26
Net Debt / EBITDA-1.82-1.82-1.51-2.14-1.80-2.66-3.21-2.13-3.50-1.83-1.63
Debt / FCF—-1.54-1.79-2.28-2.23-2.95-3.63-3.76-3.47-2.32-3.76
Interest Coverage———————————

Net cash position: cash ($702M) exceeds total debt ($39M)

DLB Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio3.173.172.863.524.725.585.794.504.784.123.57
Quick Ratio3.103.102.783.444.645.545.704.404.694.013.49
Cash Ratio1.601.601.382.272.954.034.223.014.053.593.01
Asset Turnover—0.420.410.430.460.410.400.440.370.430.44
Inventory Turnover5.265.264.174.286.0011.865.734.984.874.726.66
Days Sales Outstanding—138.49146.99124.79122.18118.20107.35113.34115.7825.7227.39

DLB Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield2.6%1.8%1.6%1.3%1.5%0.9%1.3%1.2%0.9%1.0%0.9%
Payout Ratio49.6%49.6%43.8%51.5%54.4%28.7%38.3%30.4%158.5%28.3%26.0%

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield5.2%3.6%3.6%2.5%2.8%3.2%3.5%3.8%1.6%3.4%3.3%
FCF Yield9.0%6.1%4.0%4.4%3.9%4.1%4.1%3.2%3.6%4.6%2.5%
Buyback Yield3.4%2.3%2.7%2.3%8.5%2.9%2.9%5.4%2.3%2.0%2.1%
Total Shareholder Yield6.0%4.1%4.3%3.7%10.0%3.8%4.3%6.6%3.2%2.9%2.9%
Shares Outstanding—$97M$97M$98M$102M$105M$103M$105M$107M$103M$102M

Key Metrics

Growth RegimeMixed
ProfitabilityStrong
Balance SheetFortress
Cash FlowMixed
Top Statement Risk

Royalty-free codec adoption

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Premium Valuation Reflects IP Moat

According to current market data, DLB trades at a forward P/E of 12.41, which appears to discount the company's high-margin licensing model relative to peers like Qualcomm, suggesting that investors remain cautious about the long-term durability of its royalty streams in an increasingly open-source technology landscape.

The valuation gap between DLB and higher-multiple peers suggests the market is pricing in significant terminal value risk from royalty-free alternatives. While the forward P/E is modest, the PEG ratio of 6.60 indicates that current growth expectations are expensive, implying that the market requires more evidence of successful diversification into new verticals like automotive before re-rating the stock.

Capital Efficiency Constrained by R&D

Based on reported financial statements, ROIC has fluctuated between 1.1% and 4.7% over the last ten quarters, indicating that the company's ability to compound returns on invested capital is currently hampered by the heavy R&D spending required to maintain its proprietary technology ecosystem against evolving industry standards.

The low ROIC relative to the company's high gross margins highlights the significant drag of fixed operating costs and the challenge of scaling new software-as-a-service initiatives. Investors should monitor whether the recent uptick in ROIC to 4.2% in 2026Q2 represents a sustainable improvement in capital allocation or merely a temporary benefit from favorable royalty timing.

Working Capital Cycles Impede Liquidity

As reported in recent filings, the company's cash conversion cycle remains elevated, peaking at 202 days in 2024Q3, which reflects the inherent inefficiencies of a licensing model dependent on the complex, lagged reporting cycles of global consumer electronics OEMs and the associated delays in cash collection.

The persistent DSO levels, often exceeding 130 days, suggest that the company lacks significant leverage over its large OEM partners, forcing it to carry substantial accounts receivable. This working capital intensity effectively ties up cash that could otherwise be deployed toward more aggressive growth initiatives or higher-yielding capital returns.

Misapplied Focus on P/E Multiples

The P/E ratio is frequently misapplied to this business model because it fails to account for the significant non-cash amortization of intangible assets and the volatility of audit-driven royalty catch-up payments, which can distort the perceived earnings power of the company's core intellectual property licensing engine.

Analysts should instead prioritize free cash flow yield or EV/EBITDA, as these metrics better capture the underlying cash-generative capacity of the licensing business while stripping away the noise of accounting adjustments. Relying solely on P/E risks misinterpreting the company's true financial health during periods of heavy investment in new technology standards.

Download Financial Ratios Data

Includes 30+ ratios · 23 years · Updated daily

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

DLB — Frequently Asked Questions

Quick answers to the most common questions about buying DLB stock.

What is Dolby Laboratories, Inc.'s P/E ratio?

Dolby Laboratories, Inc.'s current P/E ratio is 19.1x. The historical average is 27.1x. This places it at the 24th percentile of its historical range.

What is Dolby Laboratories, Inc.'s EV/EBITDA?

Dolby Laboratories, Inc.'s current EV/EBITDA is 11.3x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 15.1x.

What is Dolby Laboratories, Inc.'s ROE?

Dolby Laboratories, Inc.'s return on equity (ROE) is 10.0%. The historical average is 14.5%.

Is DLB stock overvalued?

Based on historical data, Dolby Laboratories, Inc. is trading at a P/E of 19.1x. This is at the 24th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What is Dolby Laboratories, Inc.'s dividend yield?

Dolby Laboratories, Inc.'s current dividend yield is 2.60% with a payout ratio of 49.6%.

What are Dolby Laboratories, Inc.'s profit margins?

Dolby Laboratories, Inc. has 88.1% gross margin and 19.6% operating margin. Operating margin between 10-20% is typical for established companies.

How much debt does Dolby Laboratories, Inc. have?

Dolby Laboratories, Inc.'s Debt/EBITDA ratio is 0.1x, indicating low leverage. A ratio below 2x is generally considered financially healthy.